News & Events
Pharmaceutical Industry Labor-Management Association (PILMA) Statement on Prescription Drug User Fee Act (PDUFA)
The Pharmaceutical Industry Labor-Management Association (PILMA) today called on members of the Senate to support the swift and streamlined process for the reauthorization of the Prescription Drug User Fee Act (PDUFA).
By every measure, PDUFA works.
A Labor-Industry Partnership in Action
On Friday, April 20, 2012, New Jersey
Senator Robert Menendez toured the
state-of-the-art Iron Workers training
facility in Springfield, NJ.
The event was hosted by the District
Council of Northern New Jersey Iron
Workers, the Healthcare Institute of
New Jersey (HINJ), the
Pharmaceutical Industry Labor
Management Association (PILMA),
and We Work For Health (WWFH).
The event was attended by representatives from Novartis,
Johnson & Johnson, the New Jersey
Steel Association, New Jersey
Building Trades, C.R. Bard, IMPACT,
BD, and members of the New Jersey
chapter of WWFH and HINJ.
The event highlighted how the
biopharmaceutical industry and
labor work together to build new
facilities, stimulate job growth,
encourage innovation, support New
Jersey’s economy and create new,
life-saving cures. Read On >
PILMA Vows to ‘Redouble’ Support
for Increased Protections Against Intellectual Property Theft
WASHINGTON, D.C.—Labor and management in the biopharmaceutical industry will “redouble efforts at the federal level to support increased protections to fight intellectual property theft, counterfeiting and piracy, along with real enforcement measures to implement those protections.”
In a resolution unanimously adopted by the trustees of the Pharmaceutical Industry Labor-Management Association (PILMA), the group applauds the ongoing efforts by labor and industry to erect strong intellectual property protections and to enforce those standards vigorously. The resolution points out that the pharmaceutical sector is “one of the few manufacturing industries that still maintains a significant employment footprint domestically, supporting more than 3.2 million American jobs.”
READ ON >
America Invents Act Will Spur New Cures
The Pharmaceutical Industry Labor Management Association (PILMA) applauds the passage of the America Invents Act and encourages President Barack Obama to sign the bill into law.
In a demonstration that Republicans and Democrats can come together in the name of jobs, the Senate voted 89 to 9 on September 8th in favor of a historic overhaul of our nation’s patent system. For industries such as the life science sector, which supports over 9 million jobs in the U.S., innovation is the key to staying globally competitive. This bill will help protect American pharmaceutical patents, spurring research to discover additional life saving cures and putting union members to work.
The member companies and unions of PILMA see this as an important step in the broader effort to strengthen intellectual property protections. We are committed to working with our allies in Congress from both sides of the aisle to continue moving this agenda forward.